Stereotaxis (STXS) Stock Overview
Designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
STXS Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Stereotaxis, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.98 |
| 52 Week High | US$3.59 |
| 52 Week Low | US$1.70 |
| Beta | 1.33 |
| 1 Month Change | 8.79% |
| 3 Month Change | -8.33% |
| 1 Year Change | -7.04% |
| 3 Year Change | -10.81% |
| 5 Year Change | -74.62% |
| Change since IPO | -97.47% |
Recent News & Updates
Recent updates
Robotic And Digital Surgery Platforms Will Reshape Long Term Endovascular Procedure Potential
Catalysts About Stereotaxis Stereotaxis develops robotic and digital systems used in endovascular surgery, with a focus on electrophysiology and cardiovascular care. What are the underlying business or industry changes driving this perspective?
Robotics And Digital Surgery Will Open New Frontiers
Strategic initiatives in robotics, digital surgery, and acquisitions might boost revenue, market size, and net margins through innovation and market expansion.Shareholder Returns
| STXS | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 3.1% | -3.5% | 1.5% |
| 1Y | -7.0% | -22.1% | 28.6% |
Return vs Industry: STXS exceeded the US Medical Equipment industry which returned -21.6% over the past year.
Return vs Market: STXS underperformed the US Market which returned 28.4% over the past year.
Price Volatility
| STXS volatility | |
|---|---|
| STXS Average Weekly Movement | 6.5% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: STXS has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: STXS's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 131 | David Fischel | www.stereotaxis.com |
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems.
Stereotaxis, Inc. Fundamentals Summary
| STXS fundamental statistics | |
|---|---|
| Market cap | US$203.29m |
| Earnings (TTM) | -US$22.95m |
| Revenue (TTM) | US$31.20m |
Is STXS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| STXS income statement (TTM) | |
|---|---|
| Revenue | US$31.20m |
| Cost of Revenue | US$14.40m |
| Gross Profit | US$16.80m |
| Other Expenses | US$39.75m |
| Earnings | -US$22.95m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.23 |
| Gross Margin | 53.86% |
| Net Profit Margin | -73.56% |
| Debt/Equity Ratio | 0% |
How did STXS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/29 06:41 |
| End of Day Share Price | 2026/05/29 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Stereotaxis, Inc. is covered by 14 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Charley Jones | Barrington Research Associates, Inc. |
| Neil Chatterji | B. Riley Securities, Inc. |
| Daniel Stauder | Citizens JMP Securities, LLC |